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A B S T R A C T
Protein aggregation in bioﬂuids is a poorly understood phenomenon. Under normal physiological conditions,
ﬂuid-borne aggregates may contain plasma or cell proteins prone to aggregation. Recent observations suggest
that neuroﬁlaments (Nf), the building blocks of neurons and a biomarker of neurodegeneration, are included in
high molecular weight complexes in circulation. The composition of these Nf-containing hetero-aggregates
(NCH) may change in systemic or organ-speciﬁc pathologies, providing the basis to develop novel disease
biomarkers. We have tested ultracentrifugation (UC) and a commercially available protein aggregate binder,
Seprion PAD-Beads (SEP), for the enrichment of NCH from plasma of healthy individuals, and then characterised
the Nf content of the aggregate fractions using gel electrophoresis and their proteome by mass spectrometry
(MS). Western blot analysis of fractions obtained by UC showed that among Nf isoforms, neuroﬁlament heavy
chain (NfH) was found within SDS-stable high molecular weight aggregates. Shotgun proteomics of aggregates
obtained with both extraction techniques identiﬁed mostly cell structural and to a lesser extent extra-cellular
matrix proteins, while functional analysis revealed pathways involved in inﬂammatory response, phagosome
and prion-like protein behaviour. UC aggregates were speciﬁcally enriched with proteins involved in endocrine,
metabolic and cell-signalling regulation. We describe the proteome of neuroﬁlament-containing aggregates
isolated from healthy individuals bioﬂuids using diﬀerent extraction methods.
1. Introduction
The formation of assemblies of proteins that have lost their soluble
state is a pathological hallmark of several neurodegenerative diseases
[1,2]. The conﬂuence of proteins into aggregates may also occur phy-
siologically as shown for the recruitment of RNA-binding proteins into
stress granules [3–7]. In cells, the aggregation of misfolded proteins is
usually kept in check by a quality control system, which operates
through protein re-folding, autophagy and clearance by the proteasome
[8,9]. Extracellularly, a range of immune mediators may contribute to
the clearance of misfolded proteins and of their aggregated forms [10].
It is proposed that in biological ﬂuids, aggregate formation reﬂects the
propensity of proteins to assemble naturally or can be experimentally
induced under conditions of stress [11–13]. Depletion of albumin from
human plasma, for example, leads to a signiﬁcant increase in protein
aggregation, particularly when heat and shear stress are applied [14].
Recently the presence of soluble sodium dodecyl sulphate (SDS) re-
sistant protein aggregates has been reported in plasma from older
adults and in signiﬁcantly lower levels in plasma from younger in-
dividuals [15]. Loss of protein homeostasis and the increased rate of
intra-cellular protein aggregation seem to be important hallmarks of
aging [15]. Therefore, aggregates found in circulation may originate
from senescent cell that have lost their functional integrity. Equally, an
age-related failure of the control of protein homeostasis (i.e., proteos-
tasis) may condition an increase of aggregation-prone proteins in ﬂuid
state and the formation of aggregates [15].
Separation of protein aggregates from ﬂuids for quality assessment
of biopharmaceutical formulations or for diagnostic purposes can be
obtained by sedimentation-density analysis using ultracentrifugation
(UC) or by extraction technologies that utilize solid-state binders. The
Seprion PAD-beads (SEP) technology, for example, has been applied to
the capture of proteins in diﬀerent states of aggregation [16]. How
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diﬀerent isolation methods compare with regards to the pool of speciﬁc
aggregates found in the extraction products and their protein compo-
sition, particularly when bioﬂuids are the source of the target particles,
is not known.
Aggregates, inclusion bodies or aggregosomes described in neuro-
degenerative diseases contain neuroﬁlaments (Nf), the building blocks
of neurons [17,18]. Nf are type IV intermediate ﬁlaments and one of the
most abundant cytoskeletal component known to stabilize axons and
maintain their size and functionality. Nf isoforms include neuroﬁlament
light (NfL, 61.5 kDa), medium (NfM, 102.5 kDa) and heavy (NfH,
112.5 kDa) chains. Post-translational modiﬁcations (PTMs), including
phosphorylation and glycosylation at amino acids Serine and Threo-
nine, aﬀect Nf properties and size which increases to 70, 170 and
200 kDa for NfL, NfM and NfH, respectively [19,20]. Nf isoforms self-
assembly and interaction with other molecules depend on conforma-
tional changes and PTMs, which also condition their immunogenicity
[21–23]. Nf are released in cerebrospinal ﬂuid (CSF) and blood when
neurons and axons degenerate, and changes of Nf levels are associated
with the progression of several neurodegenerative disorders [22,24,25].
We have recently suggested that circulating Nf are also present in high
molecular weight molecular complexes. Immunodetection of heavy
chain Nf (NfH), for example, when tested in serial sample dilutions,
lacks the linearity of the calibration curves seen with Nf recombinant
proteins or light chain Nf (NfL), a property explained by the so-called
hook eﬀect [21]. This phenomenon may relate to NfH epitopes being
masked due to sequestration into immunocomplexes or other molecular
assemblies, which is disrupted by the dilution process [21]. These data
suggest that the formation of Nf-containing hetero-aggregates (NCH) is
possible in both tissues and ﬂuids [22,24]. Understanding Nf distribu-
tion between low order oligomers and higher order hetero-aggregates
in bioﬂuids has signiﬁcant implications on their utility as biomarkers.
In amyotrophic lateral sclerosis (ALS), an invariably fatal neurode-
generative disorder, Nf form heterogenous protein aggregates [26] and
it is assumed that these are released, essentially intact, into the blood
stream following cell death. The de-novo formation of circulating het-
eroaggregates due to a seeding eﬀect of proteins like Nf in the ﬂuid
phase cannot be excluded. We hypothesise that neuroﬁlaments may be
released under both normal and pathological conditions as hetero-ag-
gregates and that the content of these formations may diﬀer between
neurologically normal and diseased individuals. Hence deﬁning the
presence and content of NCH in normal individuals is a necessary step
towards developing their utility as a new source of ALS biomarkers.
Establishing protocols for NCH isolation and molecular characterization
is therefore mandatory for any future use of NCH as disease biomarkers.
Here we studied circulating highly stable Nf-containing aggregates
in plasma of neurologically healthy individuals using gel-based se-
paration and described their protein composition. For the isolation of
these aggregates from biological ﬂuids, we have tested diﬀerent con-
ditions of ultracentrifugation including detergents and high salt con-
centrations and compared this approach to extraction obtained using
aggregate capture binders (Seprion Ligand, SEP [27]). Liquid chroma-
tography tandem mass spectrometry (LC-MS/MS) was then used to
characterize the protein content of the complexes isolated by UC and
SEP.
2. Methods
2.1. Plasma samples
Plasma samples from 6 healthy individuals with no known neuro-
logical disorders were pooled to be used in the enrichment methods.
The selected individuals were aged between 51.2 and 62.9 years at the
time of blood sampling. Neuroﬁlament heavy chain (NfH) concentra-
tion ranged from 7.0 and 42.9 ng/ml (NfH levels were determined using
immunodetection by sandwich ELISA as previously described by Lu
et al. [22]). The pooled plasma sample (PPS) was divided in 1.1 ml
aliquots and stored at − 80 °C. Ethical approval for recruitment, sam-
pling and for the experimental procedures was obtained by the East
London and The City Research Committee (09/H0703/27).
2.2. Total protein quantiﬁcation
Total protein quantiﬁcation was carried out using Pierce BCA
Protein Assay Kit (Thermo Fisher Scientiﬁc) or Bio-Rad Protein Assay
Kit (Bio-Rad) according to compatibility with reagents used in the
protocol.
2.3. Western blotting
HiMark™ pre-stained Protein Marker (Fisher Scientiﬁc UK Ltd) and
samples were loaded into 3–8% Tris-Acetate gels (Fisher Scientiﬁc UK
Ltd) and, after electrophoresis, proteins and marker were transferred
onto a nitrocellulose or polyvinylidene ﬂuoride (PVDF) membrane
(Fisher Scientiﬁc UK Ltd). The membrane was blocked with 5%
skimmed milk in TBS 0.1% Tween-20 buﬀer at room temperature for
1 h. Overnight incubation was performed with primary antibody at 4 °C
followed by incubation with secondary antibody for 1 h at room tem-
perature, with membrane washes between steps using TBS 0.1% Tween-
20. The membrane was then incubated with enhanced chemilumines-
cence substrate (ECL) and visualised using a BioRad Chemi-Doc system.
For serial probing of the same membrane with diﬀerent antibodies,
stripping with ReBlot Plus Mild Antibody Stripping Solution (Millipore)
for 15min was performed.
2.4. Nf expression in pooled plasma samples
To ﬁrst evaluate the presence of neuroﬁlaments (Nf)-containing
high molecular weight protein aggregates in pooled plasma samples
(PPS) by western blot (WB), aliquots were ﬁrst ﬁltered twice with
Amicon ﬁlters 100 K (Millipore). In this step, NfL isoform (~70 kDa)
was likely to be retained by the ﬁlter. Diﬀerent conditions known to
solubilise plasma aggregates were also employed as previously reported
and detailed hereafter [21]. Pooled plasma samples aliquots prepared
for NfH, NfM and NfL analysis were divided into three fractions and
processed as follows: 1) pre-treatment with 0.5M urea and Barb2EDTA
buﬀer for 1 h at RT, 2) dilution 1:1 with Barb2EDTA Buﬀer for 1 h at RT
and 3) left untreated at + 4 °C.
2.5. Antibodies
The following antibodies and relative dilutions (in brackets) were
used in this study: anti-Neuroﬁlaments light (NfL; 1:1000) (clone
EP675Y, Rabbit, Millipore), anti-Neuroﬁlament Medium (NfM; 1:1000)
(AB1987, Rabbit, Millipore), anti-Neuroﬁlament heavy (NfH; 1:1000)
(N4142, Rabbit, Sigma-Aldrich), Swine Anti-Rabbit Immunoglobulins
(1:50,000) (P021702-2, DAKO).
2.6. Protein aggregate enrichment methods
2.6.1. Ultracentrifugation
To identify the best conditions for enrichment of NCH using ultra-
centrifugation (UC), we tested diﬀerent detergents (SDS, Triton X-100,
Sarkosyl) at either 0.5% or 2% and diﬀerent NaCl concentrations
(0.5M, 1M, 1.5M) for salting in (Supplementary Table 1). The best
conditions were selected based on Nf detection, both in native and
within high MW forms. Total protein concentration was measured to
evaluate sample protein enrichment (Supplementary Fig. 1). 111 µl of
20% Triton X-100 was added to 1ml of PPS (ﬁnal concentration 2%
Triton X-100) and incubated in agitation for 10min at RT. Cen-
trifugation at 21,000g for 15min was performed at RT and supernatant
was collected for ultracentrifugation (UC). At this stage, 800 µl Sucrose
Cushion (1M sucrose, 50mM Tris-HCl, 1 mM EDTA and 2% Triton X-
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100) was added into each UC tube (Open-Top/Self-Seal, PA,
8× 51mm, Science Services GmbH) together with 500 µl of pre-
cleared plasma onto the cushion. After balancing the tubes, UC was
undertaken using a Sorvall Discovery 100SE, equipped with a TFT 80.2
rotor for 2 h at 50,000 rpm, 4 °C. The supernatant was discarded and
pellet re-suspended with PBS, 1.5 M NaCl and vortexed for 30 s for
washing. After an additional UC step of 40min at 50,000 rpm (4 °C), the
ﬁnal pellet was re-suspended in 100 µl PBS for western blotting or
100 µl 8M urea for MS analysis and stored at − 80 °C.
2.6.2. Seprion PAD-beads (Microsens Biotechnologies, UK)
The Seprion PAD-beads (SEP) isolation method is based on the
proprietary ligand eﬀect in retaining protein aggregates [27]. To
evaluate optimal binding conditions, we tested diﬀerent volumes of
samples and reagents in the ﬁnal mix (Table 1) and used WB for Nf
detection. Diﬀerent loading volumes of PPS were mixed with 200 µl
capture buﬀer and 100 µl of Seprion reagent. Seprion magnetic PAD-
beads were re-suspended and 100 µl transferred into the reaction mix-
ture, followed by 30-min incubation in agitation at RT. Beads were
washed at 95 °C for 10min and sample eluted with 4× loading buﬀer
(Fisher Scientiﬁc UK Ltd) and 50mM DTT. The ﬁnal SEP aggregate-
containing fractions were not quantiﬁed for total protein concentration
as the loading buﬀer was not compatible with the protein quantiﬁcation
methods reported above.
2.7. Proteomics analysis by LC-MS/MS
SDS-PAGE was performed with aggregate-containing samples ob-
tained using UC and SEP as described above. The gel was stained with
Imperial Protein Stain for 1 h at RT, washed overnight with ddH2O and
then cut into 15 diﬀerent fractions according to the band proﬁle. Each
gel fraction was reduced with DTT and alkylated with iodoacetamide,
then de-stained and subjected to in-gel trypsin digestion. Peptides were
extracted and freeze-dried for subsequent LC-MS/MS. Products of
Ultracentrifugation and Seprion-based extraction were re-suspended,
cleaned via zip-tip before injection. Qualitative analysis was performed
using Thermo Scientiﬁc™ OrbitrapVelos Pro mass spectrometer coupled
to an EASY-nLC 1000 (Proxeon) system. Samples were resuspended in
10 µl of 2% ACN/0.1% formic acid (FA), and then 5 µl was injected onto
a 75 µm×2 cm nanoViper C18 Acclaim PepMap100 precolumn (3
μmparticle size, 100 Å pore size; P/N 164705; Thermo Scientiﬁc) with
an additional sample loading volume of 12 µl of 0.1% FA in H2O using
the Thermo Scientiﬁc EASY-nLC 1000 system. Peptides were separated
at a ﬂow rate of 250 nl/min and eluted from the column over a 60-min
gradient starting with 0.1% FA in ACN (5–30% over 50min, then
30–80% between 50 and 54min, continuing at 80% up to 58min)
through a 75 µm×50 cm PepMap RSLC analytical column at 40 °C
(2 µm particle size, 100 Å pore size; P/N ES803; Thermo). After
Electrospray Ionisation, MS spectra ranging from 350 to 1800m/z va-
lues were acquired in the Orbitrap at 30k resolution and the 20 most
intense ions with a minimal required signal of 5000 were subjected to
MS/MS by rapid CID fragmentation in the ion trap. Protein identiﬁca-
tion was carried out with a Thermo Scientiﬁc Proteome Discoverer 1.4.
The number of spectra acquired from the instrument and ID rate
(Peptide Spectrum Matches (PSMs)/total spectra) were used to verify
the even loading of test-samples and PSMs performances to test overall
coverage within the sub-groups of proteins identiﬁed.
2.8. Bioinformatic analysis
The aggregates protein proﬁle was analysed using Protein
ANalysisTHrough Evolutionary Relationships (PANTHER, version 12.0
http://pantherdb.org/), a classiﬁcation system in GO terms for large-
scale data mining [28], and Webgestalt (WEB-based Gene SeTAnaLysis
Toolkit, 2017 http://webgestalt.org/option.php), a functional enrich-
ment analysis tool [29]. Bioinformatics analysis was performed to study
the UC and SEP fractions and compare the range of aggregate-con-
taining proteins the two methods had captured. With a focus on the
origin of the protein pools, analysis was initially performed to dissect
features related to Cellular Component (CC). KEGG pathway enrich-
ment was also undertaken to identify pathways and biological features
in the protein mix within the fractions isolated by UC and SEP. False
Discovery Rate (FDR) was chosen as the statistical parameter to select
the most relevant KEGG pathways [30].
3. Results
3.1. Neuroﬁlaments are present in plasma
To minimize sample variability, we pooled plasma samples from six
healthy donors. The presence of Nf, both free and within aggregates,
was investigated in this pooled plasma sample (PPS) following ultra-
ﬁltration (repeated twice) with a 100 kDa cut-oﬀ ﬁlter, to concentrate
Nf species in plasma and increase their detection by western blot (WB).
The retained fraction was subjected to western blot (WB) as previously
described [21]. One of the samples was treated with 0.5 M urea to
dissolve potential aggregates. Fig. 1 shows the presence of NfH and NfM
in the pooled plasma samples (PPS) at the expected molecular weights
(MW). A lower than expected NfL-reactive band was also detected at
approximately 30 kDa (expected MW~70 kDa), possibly related to the
release of a NfL fragment from protein complexes retained by the ﬁlter,
by the SDS detergent used in the WB procedure. No SDS-stable im-
munoreactive bands above the expected Nf MW's were identiﬁed, ir-
respective of the use of urea, and Nf bands intensity and MW appeared
comparable across conditions. We show that all three Nf isoforms are
present in plasma, and possibly, at least for NfL, as part of high-mole-
cular weight assemblies (> 100 kDa, based on ultraﬁltration). To in-
vestigate this, we proceeded to enrichment of high molecular weight
assemblies by sedimentation analysis using ultracentrifugation.
3.2. Conditions of enrichment by ultracentrifugation
We initially compared various conditions for ultracentrifugation by
altering the amount of salt (NaCl) and detergents, e.g. SDS and Triton X-
100 (Supplementary Material Table 1). Pre-treatment of samples with a
ﬁnal concentration of 2% Triton X-100, centrifugation with a 1M su-
crose cushion and pellet washing using 1.5M NaCl was associated with
a clear detection of NfL, NfM and NfH by WB (Supplementary Material,
Fig. 1). Under these conditions, NfH was consistently present at high
MW (more than 200 kDa), while NfM and NfL both migrated at the
same MW (117 kDa and 30 kDa respectively) reported for Nf detection
in un-processed PPS (Fig. 1; Supplementary Material, Fig. 1). The de-
tection of high MW, SDS-stable, NfH-containing bands in the extraction
products is in keeping with the presence of circulating, NfH-containing
protein aggregates.
Table 1
Conditions for aggregate enrichment by Seprion Magnetic PAD-Beads: volumes
of samples and reagents; CB: Capture Buﬀer; SR: Seprion-PAD Reagent.
Seprion Enrichment Condition
Reagent 1 2 3 4 5 6 7
Sample [µl] 800 400 400 400 400 400 200
CB [µl] 200 400 200 200 400 400 200
Water [µl] 0 0 200 200 0 0 400
SR [µl] 100 200 100 100 100 100 100
Beads [µl] 100 200 200 100 200 100 100
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3.3. Enrichment of neuroﬁlament-containing aggregates by Seprion PAD-
beads (SEP)
Having established a method to isolate Nf-containing protein ag-
gregates from plasma by UC, we next compared it to aggregate-isolation
with SEP [31], using the same pooled plasma samples (PPS) as test-
material under condition 1, starting with 800 µl of PPS (Table 1). SDS-
PAGE and WB were employed to assess the presence of Nf in the iso-
lated fractions prepared by UC or captured by SEP. SDS-PAGE analysis
of these fractions showed considerably diﬀerent protein migration
patterns (Fig. 2A), indicating that the two methodologies enrich dif-
ferent sets of aggregates and proteins.
We next examined the enriched samples for the presence and mi-
gration patterns of neuroﬁlaments. In the pellets after UC, as show in
Fig. 1, all three Nf isoforms were detectable (Fig. 2B). NfH was present
as a high, SDS-stable, MW band migrating above the 460 kDa marker
(Fig. 2B, upper panel, arrow). In comparison, WB analysis of NfH in PPS
prior to ultracentrifugation showed only the expected 238 kDa band
with no higher molecular weight bands (Fig. 1). This suggests that UC-
processing successfully enriches NfH-containing macromolecular for-
mations otherwise not detectable, most likely due to low concentration
in un-processed plasma. We detected three forms of NfM in the ag-
gregate fraction (Fig. 2B, middle panel), with the most intense mi-
grating at the same MW (117 kDa) as observed in non-enriched PPS
(Fig. 1). In common with the un-processed PPS, NfL appeared only as a
possibly truncated product at around 30 kDa (Fig. 2B, lower panel and
Fig. 1).
WB analysis of SEP-captured samples showed several NfH-reactive
bands but none of these migrated above the expected 238 kDa band
seen in the un-processed samples (Fig. 2C, upper panel and Fig. 1).
Similarly, NfM migrated at various MW, including above 200 kDa
(Fig. 2C, middle panel). The most intense of these anti-NfM bands ap-
peared at around 55 kDa and was also observed in the aggregate frac-
tion obtained using UC, possibly representing an immunoreactive
fragment of the full-size protein. No NfL band was observed in the SEP-
captured fraction, either at the expected or at any other MW (Fig. 2C,
lower panel).
3.4. LC-MS/MS proteomics of UC and SEP fractions
We next used proteomics to compare the protein contents of the
enriched fractions isolated from PPS by UC and SEP. We separated
comparable amount of total protein from these samples by SDS-PAGE
(Fig. 3A). Each lane was divided into 15 individual sections and sub-
jected to in-gel tryptic digestion followed by LC-MS/MS analysis. We
identiﬁed 369 and 605 protein groups for UC_PPS and SEP_PPS re-
spectively (Fig. 3; identiﬁed protein ﬁle). Nf proteins were not detected
using LC-MS/MS in neither the UC_PPS nor in the SEP_PPS, possibly due
to the occurrence of complex PTMs and the low abundance of Nf pro-
teins, (see Discussion for more details). Approximately a third (30%,
225/749) of the identiﬁed proteins were detected by both extraction
methodologies (Fig. 3B). The larger number of proteins observed in the
SEP_PPS analysis was not due to unequal sample loading, as UC_PPS
and SEP_PPS fractions had the same number of spectra acquired from
the instrument and a comparable ID rate (Peptide Spectrum Matches
(PSMs)/total spectra; Table 2). However, UC_PPS appeared to have a
higher coverage and number of PSMs per protein group, suggesting that
this extraction method was more selective in the enrichment of speciﬁc
proteins. The UC_PPS and SEP_PPS shared proteins had higher protein
coverage and PSMs counts than those seen in either of the individual
enrichment methods, suggesting that these shared proteins were more
abundant in plasma (Table 2). The lists of shared proteins and of pro-
teins speciﬁc to each aggregate-enrichment method were analysed for
enrichment of cellular component (CC) and KEGG [32] pathway terms,
using PANTHER [28] and Webgestalt [29] respectively.
3.4.1. UC and SEP-shared proteomic data analysis
PANTHER classiﬁcation analysis of the 225 entries shared by UC
and SEP identiﬁed 196 proteins, with 138 hits within the Cellular
Component (CC) (Fig. 4A). Of these, 47 proteins (34.1% of the total
hits) were classiﬁed as Cell Part, the majority being intracellular (35,
67.3%), and extracellular region (47, 34.1%). The other two main CC
were macromolecular complexes (15.2%) and organelles (10.9%). Ten
proteins within the organelles category were classiﬁed as cytoskeletal
proteins. The top 10 enriched features obtained using KEGG pathway
analysis of the shared fraction are shown in Table 3. Most pathways
were linked to infection and immune response (Staphylococcus aureus
infection, pertussis, systemic lupus erythematosus, pathogenic Escher-
ichia coli infection, complement, platelet activation) with the re-
maining related to cell migration (adhesion), extra-cellular matrix and
prion disease. As highlighted by PANTHER analysis, the cellular com-
ponents involved in these pathways were related with extracellular
region and cell part terms.
Fig. 1. Western blot analysis of pooled plasma sample (PPS) using anti-neuro-
ﬁlament-High (NfH), anti-Medium (NfM) and anti-Low (NfL) antibodies after
ﬁltration with Amicon 100 ﬁlters (100 kDa molecular cut-oﬀ). Lanes contain in
order from left to right: PPS subjected to pre-treatment with 0.5M urea and
Barb2EDTA buﬀer for 1 h at RT, PPS diluted 1:1 with Barb2EDTA Buﬀer for 1 h
at RT and untreated PPS kept at + 4 °C. The blots show the three neuroﬁlament
proteins, with NfL appearing at approx. 30 kDa, NfM at 117 kDa and NfH at
238 kDa. No bands with molecular weight higher than the expected sizes, in-
dicative of stable Nf-containing aggregates, were detected.
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Fig. 2. Comparison of aggregate fractions extracted from pooled plasma samples (PPS) using ultracentrifugation (UC) and Seprion extraction Pads (SEP). (A):
Comassie-stained SDS-PAGE gel showing the diﬀerent protein proﬁles of the enriched fractions extracted using the two methodologies. (B-C): western Blots analysis
showing presence of Nf within the aggregates fractions obtained through UC (B) and SEP (C). Arrow highlights the presence of anti-NfH-containing high MW band.
Fig. 3. UC and SEP aggregates fractions for LC-MS/MS
analysis. (A) SDS-PAGE showing gel bands dissected for in-
gel Trypsin digestion for LC-MS/MS (a total of 15 for both
UC and SEP) (same picture shown in A); (B) Protein
Identiﬁcation performed with Proteome Discoverer 1.4
generated 369 and 605 proteins unique to UC and SEP
respectively; 225 were shared by the two extraction
methods (2 peptides for protein as minimum and a peptide
count only in the top scored proteins were utilized). UC:
ultracentrifugation; SEP: Seprion extraction pads.
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3.4.2. UC-speciﬁc proteomic data analysis
PANTHER generated 99 Cellular Component proteins (105 hits)
from the LC-MS/MS analysis of the UC_PPS fraction (Fig. 4B). Of these,
40% were classiﬁed as derived from the extracellular region, 28.6% as
cell part and 25.7% as macromolecular complex, while the rest be-
longed to extracellular matrix (1.9%) and organelles (3.8%). 26.7% of
the cell part component was made of intracellular proteins and 73.30%
was plasma membrane, while 20% of the organelle component was part
of the cytoskeleton. Functional analysis by KEGG (Table 4) revealed a
signiﬁcant representation of features involved in endocrine, metabolic
and cell-signalling regulation (PPAR, thyroid hormone synthesis, lysine
degradation, carbon metabolism, citrate-TCA cycle) and pathways
speciﬁc to ECM-receptor interaction, phagosome and adipocytokine
signalling.
3.4.3. SEP-speciﬁc proteomic data analysis
From the 380 unique proteins obtained by LC-MS/MS analysis of the
SEP fraction, PANTHER identiﬁed 306 proteins generating 202 hits
within Cellular Component (Fig. 4C). The main component was cell part
(52.5%), of which 79.7% were intracellular and 18% were plasma
membrane proteins, followed by organelle (21.3%) and
macromolecular complex (12.4%) components, while extracellular re-
gion, cell junction, membrane, synapse and extracellular matrix ac-
counted for 13.9% of the total hits. Most of the organelle sub-compo-
nent proteins were related to the cytoskeleton (53.2%). KEGG
functional analysis identiﬁed features related to immune activation
(chemokine signalling pathway, focal adhesion, shigellosis, platelet
activation) and to cell function and structure (tight junction, regulation
of actin cytoskeleton, vascular smooth muscle contraction, Table 5). All
pathways showed enrichments with a FDR< 0.1.
3.5. Pro-aggregation proteins
We then interrogated the Curated Protein Aggregation Database
(CPAD) database [33], to evaluate whether proteins with known pro-
aggregating properties were in our LC-MS/MS datasets. Of the 27
human pro-aggregating proteins in the database, four were found in
both the UC_PPS and SEP_PPS proteomes (Gelsolin, Apolipoprotein A-I,
Kerato-epithelin, Lysozyme C) and two uniquely in the SEP_PPS fraction
(Semenogelin-1; Lactoferrin).
Table 2
MS analysis of enriched aggregates: main features of the protein groups identiﬁed using Proteome Discoverer 1.4. Data are shown for the protein groups identiﬁed by
ultracentrifugation only (UC), by Seprion Pads only (SEP), or “shared” by the two enrichment methods. The shared fraction included only the protein isoforms in
common and not the parental proteins: coverage values are normally distributed and the mean was used for comparison.
fraction total
spectra
total PSMs ID rat% protein
groups
Coverage%/ protein
group (mean)
#Unique Peptides/
protein group (median)
#Peptides/ protein
group (median)
#PSMs/ protein
group (median)
UC 215,993 35,779 16.56 371 31.2% 5.0 6.0 12.0
SEP 210,875 34,865 16.53 609 25.6% 5.0 6.0 8.0
UC (shared) 209 34.7% 7.0 10.0 28.0
SEP (shared) 209 35.3% 8.0 10.0 21.0
Fig. 4. Bioinformatics analysis of the MS proteomics data
of the aggregate extraction products obtained using
Protein Analysis THrough Evolutionary Relationships
(PANTHER). Pie charts representing Cellular Component
(CC) category composition in (A) shared proteins between
UC and SEP, (B) unique proteins detected by UC and (C)
by SEP. In brackets, the number of proteins identiﬁed by
PANTHER for each group.
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4. Discussion
The detection of Nf in biological ﬂuids is one of the most promising
biomarkers of neurodegeneration, but its use is complicated by the
apparent non-linearity of detection in serial dilutions. We have pre-
viously suggested that this caveat is the result of Nf, in particular the
heavy chain, being sequestered into stable protein aggregates, masking
epitopes from immunodetection. Here we show that Nf are part of high-
molecular weight hetero-aggregates in blood. Such circulating protein
aggregates may convey information on proteinopathies linked to spe-
ciﬁc organ pathologies, thus functioning as a novel source of disease
biomarkers.
Most of the experimental work produced so far on the detection and
quantiﬁcation of protein aggregates has been undertaken in tissues and
cell systems [34–37]. In the ﬁeld of neurodegeneration, for example,
protein aggregates are generally initiated by speciﬁc “seed” proteins
such as Tau and beta-amyloid. These aggregates are normally isolated
using ultracentrifugation, membrane ﬁlter assays and magnetic‐bead
immune-aﬃnity pull downs, with little attention for the wide range of
other co‐aggregated proteins [34–37]. The emerging evidence that
diﬀerent stages of protein aggregation can be also seen in bioﬂuids and
the idea that this phenomenon could somehow reproduce brain pa-
thology has moved this ﬁeld of investigation towards the character-
ization of the ﬁbrillary and aggregated state of proteins as potential
disease biomarkers [15,38]. Therefore, the development of sound
methodologies for the isolation and characterization of circulating
protein aggregates from bioﬂuids is critical not only for diagnostic
purposes but also for monitoring the eﬃcacy of anti-aggregation
therapies currently being developed.
Our study indicates that the choice of methodology for extraction of
circulating aggregates is critical to the information likely to be ob-
tained. Sedimentation and binders exploit diﬀerent physical properties
in the enrichment process, with the latter based on aﬃnity for proteins
involved in diﬀerent levels of aggregation [39]. Our data show that
Seprion technology isolates a higher number of proteins, an observation
that may be explained by Seprion's broader aﬃnity to any conforma-
tional change, which aﬀect protein-protein interactions. As a result, it is
less certain that proteins identiﬁed following Seprion enrichment are
truly part of hetero-aggregates and not simply co-isolated disordered
monomers or low order multimers. It is particularly interesting to note
that the two separation methods yielded diﬀerent proﬁles of neuroﬁ-
lament content. The diﬀerent molecular weights for NfH and NfM re-
covered by both methods and the lack of NfL detection in the Seprion
enriched-material suggest that these methods may sample diﬀerent
molecular entities. This phenomenon may be driven by post-transla-
tional modiﬁcations (PTMs) of neuroﬁlaments or of other proteins
which ultimately aﬀect their binding to Seprion. Whilst such in-
vestigation is beyond the purpose of the current study, it would possible
to perform enhanced search of the mass spectrometer raw data ﬁles to
include multiple PTM's. UC separation on the other hand is relying only
on density and may thus predominantly capture large and dense ag-
gregates and not the initial, lower molecular weight seeding species.
Nevertheless, UC separation seems to be more stringent, generating a
smaller and possibly less complex proteome, while acquiring, on
average, more spectra for the same peptide. This shows that although
the UC enrichment method coupled with MS analysis produces a
smaller share of information in terms of number of proteins, it may also
generate less false positive information in protein identiﬁcation com-
pared to Seprion. Seprion methodology may be used in experimental
settings where exploratory studies are performed to identify a broad
range of altered protein targets which escape proteostatic control [15].
MS proteomics shows that aggregates extracted from healthy in-
dividual plasma samples using UC and SEP mostly harbour cellular
components and extracellular matrix proteins. Functionally, both ex-
traction techniques identify proteins networked within inﬂammatory
processes, particularly complement factors, along with phagosome andTa
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prion-related proteins. However, qualitative diﬀerences have emerged
in the protein pools of the aggregates extracted using the two meth-
odologies. UC aggregates are speciﬁcally enriched with proteins in-
volved in endocrine, metabolic and cell-signalling regulation, while SEP
aggregates show enrichment in proteins involved in cellular processes
and in the immune system. Overall, it could be speculated that these
hetero-complexes contain biological factors that are essential in main-
taining homeostasis, like those regulating inﬂammation and metabo-
lism, while they may also act as sinks for the sequestration of other
proteins whose concentration increases with the development of pa-
thological conditions.
In this study, we have conﬁrmed by Western blot that Nf are in-
cluded in high molecular weight complexes in plasma as previously
anticipated [21,22]. Our data also strengthen the hypothesis that NfH is
more likely to be sequestered into metastable, circulating aggregates
while smaller and perhaps less complex Nf isoforms like NfL are not, in
line with the reported NfL linearity when tested in dilution curves
compared to the hook eﬀect seen with NfH [24]. However, despite the
immunoblotting detection of Nf in both UC and SEP fractions, we did
not identify Nf in either fraction using MS. As the plasma used in this
study was derived from healthy individuals, it is likely that Nf levels
would have been lower than in established neurodegenerative diseases
such as ALS. Nf low levels escaping detection by standard MS pro-
teomics may also be related to the prevalence of circulating protein
aggregates non containing Nf which can mask the detection of NCH,
likely to be far less represented in healthy individuals. It is also possible
that NfH in circulating aggregates may not be readily digestible [15]
using trypsin, with resulting peptides that are too big for the mass-to-
charge range that has been selected for our bottom-up proteomic ap-
proach. To this end, it may be worth considering whether Nf found in
circulating protein complexes may have a modiﬁed protease resistance
which condition their propensity to form aggregates. Furthermore, all
Nf isoforms are subjected to a variety of post-translational modiﬁca-
tions [40,41] which inﬂuence the detection of tryptic peptides without
employing specialized strategies. The KSP (Lysine-Serine-Proline) re-
peats positioned in the Nf tail are often the subjects of complex PTMs
and therefore, may escape detection when MS-based proteomics is ap-
plied, particularly when using trypsin, LysN or LysC. To test this hy-
pothesis, we re-submitted unmatched spectra to search against a Nf-
only sequence database. Searching was performed for tryptic peptides
with variable phosphorylation of serine, threonine and tyrosine re-
sidues and N-Glycosylation, two major post-translational modiﬁcations.
Whilst we could match several spectra to Nf, using this approach, the
statistical analysis was inherently weakened by the relatively small size
of the created database. Further optimisation of the analysis may be
undertaken in the future to convincingly identify Nf in bioﬂuids by MS-
based proteomics.
Our experimental approach has so far targeted the protein compo-
nent of complexes which may be heterogeneous, as the presence of
nucleic acids and lipids within these formations cannot be excluded.
This is particularly important in neurodegenerative conditions where
the presence of both RNA and RNA–binding proteins have been shown
to mediate protein aggregation/phase transition and to be required for
recruitment into stress granules [3]. It should also be noted that the
potential of the analytical approach described in this paper will have to
be further evaluated in a pathological context, where the hypothesis to
be tested is whether the circulating aggregate could function as a re-
porter of pathologies like neurodegenerative disorders and whether it
plays a role in the processing and/or transport of centrally produced,
conformationally altered proteins. As Nf are found in bioﬂuids, it is
tempting to speculate that other brain-speciﬁc proteins which are also
aggregation-prone may follow the same path, enhancing protein ag-
gregation in the ﬂuid phase. While not identical to aggregates found in
brain under pathological conditions, these circulating protein com-
plexes may bear some of the features of these neurological formations,
providing a useful test-bed for the development of future phase-speciﬁc
biomarkers.
While UC and Seprion-based technologies may be the methods of
choice for aggregates separation, they may also present diﬀerent sen-
sitivities for the selection of disease-speciﬁc proteins which are pack-
aged within circulating hetero-complexes.
5. Conclusions
In this study, we have tested diﬀerent modalities for the isolation
from plasma of NCH and obtained a detailed characterization of their
proteome. As for Nf, we believe that NCH composition may provide a
biomarker for several neurodegenerative diseases, particularly amyo-
trophic lateral sclerosis (ALS), where Nf levels in bioﬂuids have a strong
prognostic value [22,25,42,43]. We also postulate that any organ-spe-
ciﬁc or systemic pathological state involving protein catabolism or
homeostasis, may promote the formation of unique aggregates in bio-
ﬂuids providing the ground to uncover novel disease biomarkers for
clinical monitoring.
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